 CAMBRIDGE, Mass., Jan. 04, 2023 GLOBE NEWSWIRE -- Cerevel Therapeutics, Nasdaq: CERE, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced that chairperson and chief executive officer Tony Coles, M.D., will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference. Dr. Coles will be joined by additional members of the executive team for the question-and-answer portion of the presentation. 